I can say that Dr. Zeevi appears as our new CSO in

I can say that Dr. Zeevi appears as our new CSO in the Feb investor presentation. I am not sure why the website isn't updated yet. I do understand that this industry is being flooded with new research and new patent applications and certainly understand the stealth mode the company continues to operate in. I noticed the multitude of new studies being planned by the likes of companies such as AXIM and GWPH and actually noticed GW had a patent application for the treatment of MM using cannabis that was filed after ours and has since been removed. Things are certainly heating up. The company is remaining confident in it's success it seems. Being able to attract such talent for some shares in the company is indicative of future success in my opinion and seem quite comfortable and content holding this for years to come. I wish I knew more about how much time Dr. Zeevi is committing to our team, but according to Dr. Hirsch, from the conference, we are ramping up and now have the capital to do so. While the companies approach to releasing only SEC required correspondence is tough and feels risky for many, I have more than enough data to support a long investment here. Remember there are only a handful of real companies doing actual trials and with the rapid adoption of medical marijuana across the world we are in a very privileged place as shareholders very early on.